Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by IFP Advisors Inc

IFP Advisors Inc lowered its holdings in Surgery Partners, Inc. (NASDAQ:SGRY – Get Rating) by 36.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,100 shares of the company’s stock after selling 1,200 shares during the quarter. IFP Advisors Inc’s holdings in Surgery Partners were worth $34,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in SGRY. Allspring Global Investments Holdings LLC increased its holdings in shares of Surgery Partners by 139.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,379 shares of the company’s stock valued at $32,000 after purchasing an additional 804 shares in the last quarter. Signaturefd LLC acquired a new stake in shares of Surgery Partners during the 3rd quarter valued at approximately $43,000. Great West Life Assurance Co. Can purchased a new stake in shares of Surgery Partners during the 3rd quarter worth approximately $44,000. PNC Financial Services Group Inc. boosted its stake in shares of Surgery Partners by 34.7% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock worth $66,000 after acquiring an additional 308 shares in the last quarter. Finally, Quantbot Technologies LP purchased a new position in Surgery Partners in the 2nd quarter valued at approximately $124,000.

Surgery Partners Stock Up 0.8 %

Shares of NASDAQ:SGRY opened at $36.96 on Friday. Surgery Partners, Inc. has a 1 year low of $20.46 and a 1 year high of $41.80. The stock has a market capitalization of $4.67 billion, a P/E ratio of -40.17 and a beta of 2.74. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.68 and a current ratio of 1.83. The stock has a 50-day simple moving average of $35.21 and a 200-day simple moving average of $31.71.

Surgery Partners (NASDAQ:SGRY – Get Rating) last announced its earnings results on Monday, May 1st. The company reported $0.05 EPS for the quarter, beating the consensus estimate of ($0.04) by $0.09. The business had revenue of $666.20 million for the quarter, compared to the consensus estimate of $644.16 million. Surgery Partners had a positive return on equity of 0.59% and a negative net margin of 3.51%. Equities analysts forecast that Surgery Partners, Inc. will post 0.31 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have weighed in on SGRY shares. Cantor Fitzgerald initiated coverage on Surgery Partners in a report on Thursday, April 20th. They issued an “overweight” rating and a $43.00 target price on the stock. StockNews.com initiated coverage on shares of Surgery Partners in a research report on Thursday. They set a “hold” rating for the company. Benchmark reiterated a “buy” rating and issued a $47.00 price target on shares of Surgery Partners in a research report on Monday, March 6th. Citigroup raised their price objective on shares of Surgery Partners from $40.00 to $47.00 in a research note on Tuesday, May 2nd. Finally, JPMorgan Chase & Co. reduced their target price on Surgery Partners from $45.00 to $40.00 and set a “neutral” rating on the stock in a research note on Thursday, March 2nd. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $43.27.

Insider Transactions at Surgery Partners

In related news, insider Bradley R. Owens sold 7,191 shares of Surgery Partners stock in a transaction on Wednesday, May 17th. The shares were sold at an average price of $36.31, for a total transaction of $261,105.21. Following the sale, the insider now owns 74,189 shares of the company’s stock, valued at approximately $2,693,802.59. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Surgery Partners news, CEO Jason Eric Evans sold 7,674 shares of the firm’s stock in a transaction that occurred on Friday, March 31st. The stock was sold at an average price of $34.26, for a total transaction of $262,911.24. Following the completion of the sale, the chief executive officer now owns 426,790 shares in the company, valued at approximately $14,621,825.40. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Bradley R. Owens sold 7,191 shares of the company’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $36.31, for a total value of $261,105.21. Following the completion of the transaction, the insider now directly owns 74,189 shares in the company, valued at $2,693,802.59. The disclosure for this sale can be found here. Over the last three months, insiders have sold 75,634 shares of company stock valued at $2,526,594. Corporate insiders own 3.30% of the company’s stock.

Surgery Partners Company Profile

(Get Rating)

Surgery Partners, Inc is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services.